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Abstract 
Bayesian networks (BNs) have received increasing research attention that is not matched by adoption 
in practice and yet have potential to significantly benefit healthcare. Hitherto, research works have not 
investigated the types of medical conditions being modelled with BNs, nor whether any differences 
exist in how and why they are applied to different conditions. This research seeks to identify and 
quantify the range of medical conditions for which healthcare-related BN models have been proposed, 
and the differences in approach between the most common medical conditions to which they have 
been applied. We found that almost two-thirds of all healthcare BNs are focused on four conditions: 
cardiac, cancer, psychological and lung disorders. We believe that a lack of understanding regarding 
how BNs work and what they are capable of exists, and that it is only with greater understanding and 
promotion that we may ever realise the full potential of BNs to effect positive change in daily healthcare 
practice. 
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1. Introduction 
Bayesian Networks (BNs) have received increasing attention during the last two decades 
[1, 2] for their particular ability to be applied to challenging issues and aid those making decisions 
to reason about cause and outcome under conditions of uncertainty [3-5]. In 2016, the journal 
Machine Learning ran a special issue on Machine Learning for Healthcare and Medicine [6]. In 
explaining their motivation for that issue, the editors discussed how ever-increasing volumes of 
health data created potential for developing new knowledge that could improve the practice of 
patient care. Machine learning (ML) and artificial intelligence (AI) approaches have been 
proposed for a diverse range of health topics from genomics [7, 8] to treatment selection [9, 10] 
and outcome, prognosis, prediction [11]. A significant benefit of BNs over methods of pure ML 
from data is that BNs do not explicitly require massively large datasets. BNs can incorporate the 
accumulated knowledge of experts in circumstances where data are limited, and still produce 
meaningful and accurate decision-support systems. This paper is part of a larger effort to address 
the wide chasm between research enthusiasm for BNs and their lack of adoption in healthcare. 
The paper seeks to understand the medical conditions BNs are being used to model and make 
predictions for, and any apparent differences in their application between clinical domains, in 
order to shed light on how we may harness the potential of BNs in daily healthcare practice. 
BNs are based on Bayes’ theorem and use a graphical approach for compact 
representation of multivariate probability distributions and efficient reasoning under uncertainty 
[2]. Bayes’ theorem is a formula for understanding how belief in the probability of phenomenon 
under observation evolves as knowledge of related influential phenomena increases [12, 13]. For 
instance, where multiple diseases present with similar symptoms making differential diagnosis 
challenging, clinicians must update their degree of belief about which illness is causing the 
patient’s poor health as new information becomes available from diagnostic tests and physical 
examination of the patient.   
There are three approaches for developing a BN; (1) using only data (data-driven BNs) 
(2) using only knowledge (expert-driven BNs), and (3) using a combination of both data and 
knowledge (hybrid BNs). Expert-driven and hybrid BNs, which supplement data with knowledge, 
could potentially be the most capable approach for supporting Learning Health Systems (LHS), 
precision medicine, and thus enabling personalised clinical decision-making from large collections 
of aggregated health data. LHS, which include such well-known types as clinical decision support 
systems (CDSS) [14], have experienced slow adoption and are not routinely observed in clinical 
practice [15-17]. This is particularly true for those LHS based on BNs [2]. While others have 
reviewed the scope for AI and ML in healthcare [18-20], in each case BNs have been overlooked.  
Authors who have reviewed medical decision support models tend to provide a brief but 
broad brushstrokes view of either the ML or AI domain before focusing the bulk of their work on 
whichever method was their particular area of research interest. An example is [21] where the 
authors provide non-exhaustive lists and a brief glossary of domain-wide terms before focusing 
solely on learning approaches for neural networks, which are only one of a vast number of AI and 
ML types. In [18] the authors describe a list of ML algorithms but only expound on two from their 
research: support vector machines and neural networks. Attempts had been made to identify [19, 
22] and even quantify [18] the broad scope of medical conditions and clinical questions or 
activities to which ML and AI respectively are being applied. However, it was difficult from each 
author’s method and descriptions to identify: (a) the search terms they had used; (b) a list of the 
medical conditions or clinical questions; or (c) an accurate accounting of the papers identified by 
and used in each study.  
The aim of this paper is to establish the medical conditions to which BNs are being applied 
as part of our wider effort [23] to determine the potential benefits and challenges being faced by 
those seeking to integrate BNs into daily practice. This paper seeks to achieve its aim by 
identifying and quantifying the range of medical conditions for which the healthcare-related BN 
models are being considered. This paper contributes to our overall understanding of the purposes 
for which BNs are being considered as a predictive or decision-making tool in the healthcare 
domain, and the differences in approach between the most popular medical conditions to which 
they have been applied. It is only through continued research to understand the challenges and 
issues that we may in future harness the potential of BNs to affect positive change, and improve 
patient outcomes. 
This paper is organised as follows: Section 3 presents the method used to achieve the 
objectives of this paper as part of our larger scoping review. Section 4 presents the results, 
followed by a discussion of the general findings and their significance in Section 5. The paper 
concludes with a summary in Section 6. 
2. Method 
We used the literature collection from our scoping review on BNs in healthcare [25]. The 
search term used to derive that collection was: 
 
“(((Bayes OR Bayesian) AND network) OR (probabilistic AND graphical AND 
model)) AND (medical OR clinical)” 
 
Terms such as “Bayesian networks” or “graphical probabilistic models” were used here 
because they are widely used in the targeted literature. Different ways for explaining the medical 
condition do occur: in some papers the exact condition is mentioned, while in others broader 
terms such as “medical or clinical application”, “medical or clinical condition”, or “medical or clinical 
setting” are used. Our scope review settled on the broader terms “medical” or “clinical” as they 
were found in a wider collection of papers. Searching for specific medical conditions would have 
been impractical as there are many thousands of distinct known conditions. 
The search initially identified 3810 papers. Through the process displayed in Figure 1 we 
then exclude papers published before 2013, those not published in English, and any whose 
primary content was not healthcare-related. In addition, papers that did not provide BNs and 
instead were focused merely on Bayesian statistics or meta-analyses were excluded. Graphical 
models, such as naive BNs, which are the simplest BNs and structurally assume all variables are 
independent, and other graphical computational approaches used in ML or AI, including neural 
networks, have also been excluded.  
   
 
 
 
Figure 1: PRISMA diagram (from [23]) 
 
Our primary review plan identified six primary objectives that included identifying the aim 
of each reported BN, understanding the development processes and inputs used by authors, and 
how useful the resulting BN may be in clinical practice. The focus of research reported in this 
paper is Objective 5: to identify distribution and frequency of the medical conditions targeted by 
the BN models described in the literature collection used in our larger scoping review of BNs in 
healthcare. Objective 5 is identified in purple in our review concept plan [23] presented here as 
Figure 2. 
 
 
Figure 2: Concept map for the Scoping Review of Bayesian Networks in Healthcare (from [23]) 
 
The list of medical conditions in Table 1 was developed with the input of two clinical 
experts and refined inductively during a small-scale preliminary review described in [2]. Each 
paper was reviewed by two reviewers who recorded the target medical condition against the list 
which was presented to reviewers as part of a secure online survey used to manage and conduct 
the overall review. Where the medical condition was not listed, or the reviewer felt unable to make 
an explicit classification, it was possible to manually enter details or references to the condition 
from the literature into a free-text field exposed below the list. Where the two responses for a 
given paper differed, two authors (SM and EK) reviewed the paper collaboratively to achieve 
consensus. In rare circumstances where consensus could not be achieved, a clinician was 
available to assist with classification.  
 
 
 
 
 Medical Condition Exemplar 
Citations 
1 Blood disorders [61, 63] 
2 Brain or spine (including CNS injury) [64] 
3 Chronic Conditions (e.g.: diabetic and arthritic conditions) [65, 66] 
4 Cancer [30-32] 
5 Cardiac conditions [25-27] 
6 Fatigue [67] 
7 Genetic [68] 
8 Infectious diseases [69] 
9 Liver disease [70, 71] 
10 Lung and breathing disorders [46-48] 
11 Medication (concentration or reaction to) [72] 
12 Musculoskeletal Conditions [73] 
13 Oesophageal disorders (swallowing or speech) [74] 
14 Organ disorders or failure [75] 
15 Pregnancy disorders [76] 
16 Psychological or psychiatric disorders [41-43] 
17 Skin (burns or disorders) [77, 78] 
18 Sleep disorders [79] 
19 Surgery related infection [80] 
20 Utility of or experience of healthcare [81] 
21 Unclassified or Other [52, 82] 
 Table 1: list of Medical Conditions  
3. Results and Discussion 
Even though the quantity of BN literature is rapidly increasing, it was possible to identify a 
distinct focus on a small group of conditions. Specifically, as shown in Figure 3, cardiac conditions, 
cancer, psychological and psychiatric disorders, and lung and breathing disorders made up 59% 
of the medical conditions in the literature. This result was not surprising given that other research 
identified similar disease foci for AI generally [18], and the notoriety of these conditions in the 
mainstream media as those most likely to kill you [24]. The remaining 41% of papers were spread 
across a diverse collection of seemingly random topics. Figure 3 also illustrates the general 
distribution of BN literature against the entire list of medical conditions. The complete review 
dataset is available as a supplemental material spreadsheet on the PamBayesian website at 
(http://www.pambayesian.org/interim-data/).  
 
 
Figure 3: Distribution of medical conditions in BN literature 
3.1 Most Common Medical Conditions  
Cardiac conditions  
A strong theme for cardiac models was a restriction of focus to either acute 
diagnosis or prediction of disease progression. Common to many was the authors’ 
use of electronic patient data as the primary source for elements of BN structure 
and observations necessary for prediction. This, while simultaneously 
admonishing the poor quality they observed of most available electronic health 
record (EHR) data and the limitations that arose from this quality issue [25-27]. 
Proposed approaches ranged from models for classifying the diagnosis [28] or 
severity [29] of a patient’s condition, to prediction of risk for acute clinical events 
[25] and the likely progression of the individual’s disease [26]. It was not unusual 
for cardiac BNs to incorporate known comorbidities and validate their interaction 
with the patient’s cardiac condition [26, 27]. 
 
Cancer  
Breast cancer [30-32] and (onco)gene expression [33] separately, and sometimes 
together [34, 35], were targets of significant interest. BNs have been applied to 
supporting and enhancing expert knowledge in diagnosing breast cancer from 
mammography images [36], classifying tumours [30], and as a potential method to 
improve expert judgement in situations where increasingly complex treatment 
options have made clinical decisions difficult [37]. Cancer BNs were more likely to 
seek previously unknown relationships either between symptoms and syndromes 
[38], or expressed genes and target metastatic cancers [34]. 
 
Psychological and psychiatric disorders  
The most prevalent conditions modelled in the literature were depression [39-41] 
and the age-related cognitive degeneration diagnoses: dementia and Alzheimer's 
Disease (AD) [41-43]. Incorporating an organisational structure from ontologies 
and merging this with BNs was a popular approach in these medical models [39, 
44], along with a stronger focus on identifying or relying on a hierarchy of 
symptoms [39, 44]. While medical models were generally seen to be more likely to 
draw on experts’ knowledge than data alone, the nature and mystery of 
psychological and psychiatric disorders may be the reason they more frequently 
drew on clinical expertise during BN development [39-41, 43, 45].  
 
Lung and breathing disorders  
Half of all models for lung and breathing disorders sought to predict the risk of 
exacerbation of an already diagnosed chronic clinical condition, including: chronic 
obstructive pulmonary disease (COPD) [46, 47] and asthma [48]. Others sought to 
use clinical signs and symptoms to either assess the probability of a particular 
acute pulmonary diagnosis [49], predict future severity [50], or classify the subtype 
of the diagnosed disease [51]. One approach proposed a mobile smartphone app 
that used questionnaires and a BN model to ascertain the patient’s current 
condition and provide contextually relevant advice, while delivering data on the 
patient’s health status to clinicians via an internet connection and a central server 
[46]. This is similar to the approach proposed by the authors of this paper for their 
PamBayesian project (www.pambayesian.org).  
3.2 Researcher and Content Classification 
Overall, papers could generally be classified as one of three types. First, there were 
papers written entirely by computer scientists and mathematicians that whilst being dense on 
technical detail and description for the math of BNs, were sparse on clinical detail for the 
conditions being modelled - these we describe as method-driven [28, 39, 52, 53]. Second, there 
were those that were written entirely by clinicians who included comprehensive discussion and 
contextualisation of the medical condition and its symptomatology, but significantly less technical 
discussion of the theory and development of their BN - these we felt were problem-driven [54, 
55]. Finally, there were those presented by a mix of both clinicians and computing or decision 
scientists - these we describe as hybrid-driven.  
In method-driven works, the focus is mainly on the BN methodology. A medical application 
is used simply as a case study to evaluate the proposed methodology.  
For problem-driven works, it was rare to find a paper that whilst appearing to be written 
entirely by clinicians, was methodological in both its regard for the BN’s development process and 
comprehensive in its technical description of the BN generally. One such unicorn paper drew the 
attention and comments of both reviewers [56]. The reviewers also generally felt that radiologists 
came across better than most other clinical disciplines at describing the mathematical and 
technical aspects of BN development, possibly resulting from their medical physics training [57, 
58].  
In the hybrid-driven works, reviewers tended to introduce both the medical condition (the 
problem aspects) and BN theory (the methodology aspects) early [48, 59-62]. Having a 
multidisciplinary team offers the advantage that both aspects receive equal consideration. From 
the medical perspective, the research problem and benefit of the BN to clinical practice are better 
explained. From the computing point of view, the overall BN development process is described in 
greater detail. In papers where both clinicians and computer scientists are involved the BN 
development and validation process were found to possess greater accuracy, as clinical input 
was considered. 
3.3 Strengths and Limitations 
A strength of this review is that this is a component of the largest scoping review of BNs 
in healthcare [23]. Another strength is that tools, including a structured list of medical conditions 
and an online standardised survey form were developed to ensure a consistent review process. 
A limitation of this review is that, even if this is a representative sample of papers published 
in both medical and AI journals and conference proceedings, it may not reflect the entire range of 
the literature regarding BNs in healthcare. We looked for keywords such as “Bayesian Networks”, 
“probabilistic graphical models”, “medical”, “clinical” to appear in the abstract of each paper. While 
it would not constitute a significant number, it is possible that some relevant papers were not 
included because they did not use the selected keywords in their abstract. This is especially true 
in cases where the actual name of the medical condition is described without mentioning the 
words “medical” or “clinical”. However, we believe that the large number of selected papers was 
sufficient for drawing conclusions. 
4. Summary  
This paper began by recognising that while other authors had reviewed, and in some 
cases identified and quantified the medical conditions for which other AI and ML methods had 
been developed, in all cases they had eschewed BNs. This was our primary research problem. 
We also highlighted three secondary issues present in those reviews. That it was often difficult to 
identify: (a) the search terms they had used; (b) a framework or description for medical conditions; 
or (c) an accurate accounting of the papers identified by and used in each study. 
As a core component of our systematic review of BNs in healthcare, our reviewers worked 
with clinicians to develop a list for use in identifying the target medical conditions that had been 
the focus of BN modelling. To address the primary research problem, we quantified the BNs from 
our literature collection by medical condition, identifying four conditions that received the majority 
of attention from authors and reviewing papers from each of those conditions in greater detail. 
Also, to ensure we did not proliferate the three secondary issues observed of other works, we 
provided: (a) the search term and process used to arrive at our literature collection; (b) the list of 
medical conditions that reviewers were asked to use in classifying medical BNs; and (c) a URL 
link to the complete review dataset.  
BNs have and continue to receive significant interest for their ability to combine available 
evidence and accurately reason under conditions of uncertainty. This paper has contributed to 
our understanding of how and what BNs have been considered for in healthcare. We identified 
the four primary conditions that have received almost two-thirds of BN-modelling attention in the 
literature: cardiac, cancer, psychological and lung disorders. We also found a number of acute 
differences in how BNs were being applied to each.  
The wider observation is that despite the strong research interest in BN models in 
healthcare, this interest is not matched by adoption in practice. It is possible that with most BN in 
healthcare research effort going to these four primary conditions that already receive vast 
amounts of funding and attention from other solution areas, that BNs are being drowned out: 
effectively lost in the noise. It is also possible that a lack of understanding pervades with respect 
to how BNs work and what they are capable of. Either way, it is only through understanding and 
promotion, continued multidisciplinary research and adherence to the full disclosure required of 
the scientific method that we may in future harness the potential of BNs in daily healthcare practice 
and affect positive change, improving outcomes for clinicians and patients alike.  
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